Newtyn Capital Partners, LP, Director Other at MERRIMACK PHARMACEUTICALS INC (MACK), bought 112,980 shares at $3.65 ($412K) on 2020-11-12, disclosed to the SEC on 2020-11-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.65 | 23,556 | $86K | 20.8% |
| 2 | $3.65 | 23,556 | $86K | 20.8% |
| 3 | $3.65 | 32,934 | $120K | 29.2% |
| 4 | $3.65 | 32,934 | $120K | 29.2% |
| Total | $3.65 avg | 112,980 | $412K | 100% |
| Filing → |
| GTX | SELL | 2021-01-11 | $529K | — | Filing → |
| MACK | BUY | 2020-08-13 | $55K | — | Filing → |
| MACK | BUY | 2020-04-07 | $46K | — | Filing → |